BDX's PEG ratio is unavailable because the earnings growth data is negative or zero. Becton Dickinson last had a PEG ratio of 10.92 in December 2025.
A ten years lookback shows an average PEG ratio of 2.69 for Becton Dickinson. The ten years high occurred in the Sep 2017 quarter at 17.37, reflecting maximum valuation relative to growth. The minimum was hit in the Mar 2019 quarter at 0.08, indicating optimal value relative to growth during that period.
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | N/A | 32.1 | -0.9% |
| 2024 | 2.24 | 41 | 18.3% |
| 2023 | N/A | 52.02 | -16.2% |
| 2022 | N/A | 37.58 | -14.3% |
| 2021 | 0.23 | 35.52 | 151.6% |
| 2020 | N/A | 84.61 | -31.4% |
| 2019 | 0.12 | 63.08 | 546.8% |
| 2018 | N/A | 420.97 | -86.8% |
| 2017 | 17.37 | 41.69 | 2.4% |
| 2016 | 1.16 | 39.16 | 33.8% |
| 2015 | N/A | 38.68 | -44% |
| 2014 | N/A | 18.57 | -7.5% |
| 2013 | 0.91 | 15.09 | 16.5% |
| 2012 | N/A | 13.81 | -1% |
| 2011 | 5.54 | 12.75 | 2.3% |
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | N/A | 39.81 | -23.7% |
| Dec 2025 | 10.92 | 31.66 | 2.9% |
| Sep 2025 | N/A | 32.1 | -0.9% |
| Jun 2025 | 2.34 | 31.32 | 13.4% |
| Mar 2025 | 3.14 | 44.22 | 14.1% |
| Dec 2024 | 0.93 | 38.07 | 40.9% |
| Sep 2024 | 2.24 | 41 | 18.3% |
| Jun 2024 | N/A | 48.19 | -12.8% |
| Mar 2024 | N/A | 54.5 | -15.5% |
| Dec 2023 | N/A | 57.64 | -20.8% |
| Sep 2023 | N/A | 52.02 | -16.2% |
| Jun 2023 | N/A | 47.48 | -5% |
| Mar 2023 | N/A | 46.1 | -16.1% |
| Dec 2022 | N/A | 47.62 | -8.6% |
| Sep 2022 | N/A | 37.58 | -14.3% |
| Stock name | PEG ratio | Market cap |
|---|---|---|
| BIO Bio-Rad Laboratories Inc | 0.46 | $7.74B |
| LH Laboratory Corp Of America Holdings | 0.77 | $21.73B |
| RMD Resmed Inc | 1.14 | $27.96B |
| ISRG Intuitive Surgical Inc | 2.45 | $147.53B |
| TMO Thermo Fisher Scientific Inc | 3.94 | $176.04B |
| XRAY DENTSPLY SIRONA Inc | N/A | $2.03B |
| BAX Baxter International Inc | N/A | $10.75B |
| TFX Teleflex Inc | N/A | $5.76B |
| HBIO Harvard Bioscience Inc | N/A | $27.02M |
| BDX Becton Dickinson & Co | N/A | $40.1B |
BDX's PEG ratio is unavailable because EPS growth data is negative or not present.
BDX's 3-year PEG ratio average stands at 3.91.
BDX's 5-year PEG ratio average stands at 2.99.
The Sep 2017 quarter marked the ten years high at 17.37 for BDX's PEG ratio.
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.